Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteomic characterization of atopic dermatitis blood from infancy to adulthood.
Del Duca E, Renert-Yuval Y, Pavel AB, Mikhaylov D, Wu J, Lefferdink R, Fang M, Sheth A, Blumstein A, Facheris P, Estrada YD, Rangel SM, Krueger JG, Paller AS, Guttman-Yassky E. Del Duca E, et al. Among authors: mikhaylov d. J Am Acad Dermatol. 2023 May;88(5):1083-1093. doi: 10.1016/j.jaad.2022.12.050. Epub 2023 Feb 10. J Am Acad Dermatol. 2023. PMID: 36773824 Free PMC article.
Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients.
Olesen CM, Pavel AB, Wu J, Mikhaylov D, Del Duca E, Estrada Y, Krueger JG, Zhang N, Clausen ML, Agner T, Guttman-Yassky E. Olesen CM, et al. Among authors: mikhaylov d. J Allergy Clin Immunol Pract. 2021 Jan;9(1):576-579.e3. doi: 10.1016/j.jaip.2020.08.037. Epub 2020 Sep 2. J Allergy Clin Immunol Pract. 2021. PMID: 32889222 No abstract available.
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.
Ungar B, Glickman JW, Golant AK, Dubin C, Marushchak O, Gontzes A, Mikhaylov D, Singer GK, Baum D, Wei N, Sanin A, Gruenstein D, Lebwohl MG, Pavel AB, Guttman-Yassky E. Ungar B, et al. Among authors: mikhaylov d. J Allergy Clin Immunol Pract. 2022 Jan;10(1):134-142. doi: 10.1016/j.jaip.2021.10.050. Epub 2021 Nov 1. J Allergy Clin Immunol Pract. 2022. PMID: 34737108 Free PMC article.
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier Signatures.
Kim M, Mikhaylov D, Rangel SM, Pavel AB, He H, Renert-Yuval Y, Del Duca E, Malik K, Huynh T, Ibler E, Sun M, Zhang N, Estrada Y, Krueger J, Paller AS, Guttman-Yassky E. Kim M, et al. Among authors: mikhaylov d. J Invest Dermatol. 2022 Sep;142(9):2363-2374.e18. doi: 10.1016/j.jid.2022.03.022. Epub 2022 Apr 11. J Invest Dermatol. 2022. PMID: 35421402 Free PMC article.
Oral Janus kinase inhibitors for atopic dermatitis.
Mikhaylov D, Ungar B, Renert-Yuval Y, Guttman-Yassky E. Mikhaylov D, et al. Ann Allergy Asthma Immunol. 2023 May;130(5):577-592. doi: 10.1016/j.anai.2023.01.020. Epub 2023 Feb 1. Ann Allergy Asthma Immunol. 2023. PMID: 36736457 Review.
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.
Mikhaylov D, Glickman JW, Del Duca E, Nia J, Hashim P, Singer GK, Posligua AL, Florek AG, Ibler E, Hagstrom EL, Estrada Y, Rangel SM, Colavincenzo M, Paller AS, Guttman-Yassky E. Mikhaylov D, et al. Arch Dermatol Res. 2023 Mar;315(2):181-189. doi: 10.1007/s00403-022-02336-0. Epub 2022 Mar 1. Arch Dermatol Res. 2023. PMID: 35230488 Clinical Trial.
A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata.
Mikhaylov D, Pavel A, Yao C, Kimmel G, Nia J, Hashim P, Vekaria AS, Taliercio M, Singer G, Karalekas R, Baum D, Mansouri Y, Lebwohl MG, Guttman-Yassky E. Mikhaylov D, et al. Arch Dermatol Res. 2019 Jan;311(1):29-36. doi: 10.1007/s00403-018-1876-y. Epub 2018 Nov 11. Arch Dermatol Res. 2019. PMID: 30417279 Clinical Trial.
28 results